Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
32.19
+0.21 (0.64%)
Nov 22, 2024, 3:24 PM EST - Market open
Edgewise Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for EWTX stock have an average target of 41.17, with a low estimate of 31 and a high estimate of 51. The average target predicts an increase of 27.92% from the current stock price of 32.19.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for EWTX stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 4 | 4 | 4 | 4 | 4 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $45 | Buy | Initiates | $45 | +39.82% | Nov 22, 2024 |
| Wedbush | Wedbush | Buy Maintains $44 → $45 | Buy | Maintains | $44 → $45 | +39.82% | Nov 8, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $48 → $51 | Buy | Maintains | $48 → $51 | +58.46% | Oct 11, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $32 → $42 | Buy | Maintains | $32 → $42 | +30.50% | Sep 20, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $25 → $33 | Strong Buy | Maintains | $25 → $33 | +2.53% | Sep 19, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.52
from -1.57
EPS Next Year
-1.91
from -1.52
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 26.3M | ||
| Avg | n/a | n/a | 9.5M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.44 | -1.55 | -1.54 | ||
| Avg | -1.52 | -1.91 | -1.99 | ||
| Low | -1.59 | -2.23 | -2.82 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.